Ground Swell Capital’s Ultragenyx Pharmaceutical RARE Stock Holding History

Ground Swell Capital’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$3K	Buy	+48	New	+$2.42K	0.01%	1753

Other funds holding RARE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Ground Swell Capital's RARE Position: Q3 2014 in Review

Ground Swell Capital opened a new position in Ultragenyx Pharmaceutical (RARE) in Q3 2014: 48 shares worth $3K. The stake represents 0.01% of the portfolio and ranks #1753 among its holdings.

100 funds tracked by Wall St. Rank hold RARE as of Q3 2014.

Ground Swell Capital held 48 shares of Ultragenyx Pharmaceutical worth $3K as of Q3 2014.
Ultragenyx Pharmaceutical was a new Ground Swell Capital position in Q3 2014.
Ultragenyx Pharmaceutical made up 0.01% of Ground Swell Capital's portfolio in Q3 2014, its #1753 holding.
100 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.